Format

Send to:

Choose Destination
See comment in PubMed Commons below
Exp Neurol. 2013 Sep;247:359-72. doi: 10.1016/j.expneurol.2013.01.001. Epub 2013 Jan 9.

Overexpression of parkin in the rat nigrostriatal dopamine system protects against methamphetamine neurotoxicity.

Author information

  • 1Department of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI 48202, USA.

Abstract

Methamphetamine (METH) is a central nervous system psychostimulant with a high potential for abuse. At high doses, METH causes a selective degeneration of dopaminergic terminals in the striatum, sparing other striatal terminals and cell bodies. We previously detected a deficit in parkin after binge METH in rat striatal synaptosomes. Parkin is an ubiquitin-protein E3 ligase capable of protecting dopamine neurons from diverse cellular insults. Whether the deficit in parkin mediates the toxicity of METH and whether parkin can protect from toxicity of the drug is unknown. The present study investigated whether overexpression of parkin attenuates degeneration of striatal dopaminergic terminals exposed to binge METH. Parkin overexpression in rat nigrostriatal dopamine system was achieved by microinjection of adeno-associated viral transfer vector 2/6 encoding rat parkin (AAV2/6-parkin) into the substantia nigra pars compacta. The microinjections of AAV2/6-parkin dose-dependently increased parkin levels in both the substantia nigra pars compacta and striatum. The levels of dopamine synthesizing enzyme, tyrosine hydroxylase, remained at the control levels; therefore, tyrosine hydroxylase immunoreactivity was used as an index of dopaminergic terminal integrity. In METH-exposed rats, the increase in parkin levels attenuated METH-induced decreases in striatal tyrosine hydroxylase immunoreactivity in a dose-dependent manner, indicating that parkin can protect striatal dopaminergic terminals against METH neurotoxicity.

Copyright © 2013 Elsevier Inc. All rights reserved.

KEYWORDS:

AAV; AMC; AP; CNS; DA; DAB; Dopamine; METH; ML; Methamphetamine; Neuroprotection; Parkin; SAL; SDS-PAGE; SNc; Striatum; Suc-LLVY-AMC; Suc-Leu-Leu-Val-Tyr-7-amido-4-methylcoumarin; TH; TU; Toxicity; V; V(max); adeno-associated virus; amido-4-methylcoumarin; anterior–posterior; central nervous system; diaminobenzidine; dopamine; maximal velocity; medio-lateral; methamphetamine; saline; sodium dodecyl sulfate polyacrylamide gel electrophoresis; substantia nigra pars compacta; transducing unit; tyrosine hydroxylase; ventral

PMID:
23313192
[PubMed - indexed for MEDLINE]
PMCID:
PMC4321803
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Write to the Help Desk